Central African Republic vs Venezuela: The number of people with susceptibility test result for rifampicin
Central African Republic
9.75
in 2021
Venezuela
3.31
in 2021
Central African Republic rank
139th
Venezuela rank
140th
The number of people with susceptibility test result for rifampicin over time
- Central African Republic
- Venezuela
How they compare
Central African Republic currently reports 9.75 against 3.31 in Venezuela, a difference of 6.44.
That makes Central African Republic's figure about 2.9 times Venezuela's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Venezuela ahead.
Central African Republic ranks 139th and Venezuela ranks 140th of 146 countries.
Across the 2 decades both report, Central African Republic averaged higher in 1 and Venezuela in 1.
Head to head by decade
| Decade | Central African Republic | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.64 | 5.64 | 4 | Venezuela |
| 2020s | 10.12 | 2.56 | 7.55 | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Central African Republic or Venezuela?
- Central African Republic, at 9.75 against 3.31 in Venezuela as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Central African Republic and Venezuela?
- 6.44, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Venezuela?
- 5 years are reported by both, from 2017 to 2021.
- How do Central African Republic and Venezuela rank globally for the number of people with susceptibility test result for rifampicin?
- Central African Republic ranks 139th and Venezuela ranks 140th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.